PMID- 33070370 OWN - NLM STAT- MEDLINE DCOM- 20210830 LR - 20220716 IS - 1938-3673 (Electronic) IS - 0741-5400 (Print) IS - 0741-5400 (Linking) VI - 109 IP - 6 DP - 2021 Jun TI - Frontline Science: Extracellular CIRP generates a proinflammatory Ly6G(+) CD11b(hi) subset of low-density neutrophils in sepsis. PG - 1019-1032 LID - 10.1002/JLB.3HI0620-416R [doi] AB - Extracellular cold-inducible RNA-binding protein (eCIRP) is a damage-associated molecular pattern. Neutrophils present in the mononuclear cell fraction of Ficoll gradient separation are called low-density neutrophils (LDNs). Here we report the novel role of eCIRP on LDNs' heterogeneity in sepsis. Sepsis was induced in male C57BL/6 wild-type (WT) and CIRP(-/-) mice by cecal ligation and puncture (CLP). At 20 h after CLP, LDNs in the blood were isolated by Ficoll gradient separation, followed by staining the cells with anti-Ly6G and anti-CD11b Abs and detection by flow cytometry. Sepsis or recombinant murine CIRP (rmCIRP) injection in mice resulted in significant increase in the frequency (%) and number of Ly6G(+) CD11b(hi) and Ly6G(+) CD11b(lo) LDNs in the blood compared to sham- or vehicle-treated mice. At 20 h of CLP, CIRP(-/-) mice had significantly lower frequency and number of Ly6G(+) CD11b(hi) and Ly6G(+) CD11b(lo) LDNs in the blood compared to WT mice. In sepsis mice or rmCIRP-injected mice, compared to Ly6G(+) CD11b(lo) LDNs, the expression of CXCR4, ICAM-1, and iNOS and formation of reactive oxygen species, and neutrophil extracellular traps in Ly6G(+) CD11b(hi) LDNs in the blood were significantly increased. Treatment of WT bone marrow-derived neutrophils (BMDNs) with rmCIRP increased Ly6G(+) CD11b(hi) LDN frequency, whereas treatment of TLR4(-/-) BMDNs with rmCIRP significantly decreased the frequency of Ly6G(+) CD11b(hi) LDNs. BMDNs' stimulation with rmCIRP increased the expression of transcription factors in LDNs. eCIRP induces the formation of a proinflammatory phenotype Ly6G(+) CD11b(hi) of LDNs through TLR4. Targeting eCIRP may provide beneficial outcomes in sepsis by decreasing proinflammatory Ly6G(+) CD11b(hi) LDNs. CI - (c)2020 Society for Leukocyte Biology. FAU - Takizawa, Satoshi AU - Takizawa S AD - Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, New York, USA. FAU - Murao, Atsushi AU - Murao A AD - Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, New York, USA. FAU - Ochani, Mahendar AU - Ochani M AD - Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, New York, USA. FAU - Aziz, Monowar AU - Aziz M AUID- ORCID: 0000-0002-8195-4505 AD - Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, New York, USA. FAU - Wang, Ping AU - Wang P AUID- ORCID: 0000-0002-1557-0394 AD - Center for Immunology and Inflammation, The Feinstein Institutes for Medical Research, Manhasset, New York, USA. AD - Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA. LA - eng GR - R01 GM129633/GM/NIGMS NIH HHS/United States GR - R35 GM118337/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20201018 PL - England TA - J Leukoc Biol JT - Journal of leukocyte biology JID - 8405628 RN - 0 (Antigens, Ly) RN - 0 (Biomarkers) RN - 0 (CD11b Antigen) RN - 0 (Cirbp protein, mouse) RN - 0 (Ly6G antigen, mouse) RN - 0 (RNA-Binding Proteins) SB - IM CIN - J Leukoc Biol. 2021 Jun;109(6):1013-1015. PMID: 33112444 MH - Animals MH - Antigens, Ly/*metabolism MH - Biomarkers MH - CD11b Antigen/*metabolism MH - Disease Models, Animal MH - Disease Susceptibility MH - Extracellular Space/metabolism MH - Leukocyte Count MH - Male MH - Mice MH - Mice, Knockout MH - Neutrophils/*metabolism MH - RNA-Binding Proteins/genetics/*metabolism MH - Sepsis/diagnosis/*etiology/*metabolism PMC - PMC8053202 MID - NIHMS1636077 OTO - NOTNLM OT - CIRP OT - ICAM-1 OT - NETs OT - low-density neutrophil OT - neutrophil OT - sepsis COIS- Conflict of interest disclosure All authors declared that they have no competing interests. EDAT- 2020/10/19 06:00 MHDA- 2021/08/31 06:00 PMCR- 2022/06/01 CRDT- 2020/10/18 20:35 PHST- 2020/09/02 00:00 [revised] PHST- 2020/06/29 00:00 [received] PHST- 2020/10/03 00:00 [accepted] PHST- 2020/10/19 06:00 [pubmed] PHST- 2021/08/31 06:00 [medline] PHST- 2020/10/18 20:35 [entrez] PHST- 2022/06/01 00:00 [pmc-release] AID - 10.1002/JLB.3HI0620-416R [doi] PST - ppublish SO - J Leukoc Biol. 2021 Jun;109(6):1019-1032. doi: 10.1002/JLB.3HI0620-416R. Epub 2020 Oct 18.